On March 6, 2020, Alfred Altomari, a member of the Board of Directors (the “Board”) of Recro Pharma, Inc. (the “Company”), notified the company of his intention to step down from his position as a member of the Board and as a member of the audit committee and compensation committee of the Board effective March 6, 2020. Mr. Altomari resigned to focus on his role as Chairman of the Board and Chief Executive Officer of Agile Therapeutics, Inc. and to reduce the number of public company boards of directors on which he serves.